Background factors in patients receiving immunoglobulin administration and changes in sepsis markers

por Ikeda, T, Ikeda, K, Taniuchi, H, Suda, S, Takahashi, Y
Publicado 2010

New sepsis-related marker: endotoxin activity assay

por Ikeda, T, Ikeda, K, Taniuchi, H, Hiramatsu, M, Suda, S
Publicado 2010

Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections

por Ikeda, T, Ikeda, K, Taniuchi, H, Suda, S, Takahashi, Y
Publicado 2009

Can urinary 8-OHdG be a good indicator of vasospasm occurrence following subarachnoid hemorrhage?

por Ikeda, K, Ikeda, T, Taniuchi, H, Suda, S, Ikeda, Y, Jimbo, H
Publicado 2012

Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy

por Ikeda, T, Ikeda, K, Nagura, M, Taniuchi, H, Kuroki, Y, Matsushita, M
Publicado 2005

Correlation between changes in mediators and number of dysfunctional organs in sepsis-associated multiple organ dysfunction syndrome (MODS)

por Taniuchi, H, Ikeda, T, Ikeda, K, Suzuki, H, Nagura, M, Ooshima, K, Kuroki, Y
Publicado 2003

Effect of continuous hemodiafiltration (CHDF) on vascular endothelial cell function in sepsis patients

por Ikeda, K, Ikeda, T, Taniuchi, H, Suzuki, H, Nagura, M, Ooshima, K, Kuroki, Y, Endo, S
Publicado 2003

Is it true that PMX-DHP can improve lung oxygenation?

por Ikeda, T, Ikeda, K, Suzuki, H, Taniuchi, H, Nagura, M, Ohshima, K, Kuroki, Y, Matsuno, N
Publicado 2003

Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure

por Ikeda, T, Ikeda, K, Nagura, M, Taniuchi, H, Matsushita, M, Kuroki, Y, Suzuki, K, Matsuno, N
Publicado 2004